Rare diseases
Investigational molecules
Locations
Norrbackagatan 70 C, St Matteus, 113 34 Stockholm, Sweden
Oxcia AB’s clinical research is centered on blood cancers, with attention to advanced and relapsed/refractory disease settings. The current trial landscape includes acute myeloid leukemia, acute lymphoblastic leukemia, diffuse large B-cell lymphoma, multiple myeloma, and high-risk myelodysplastic syndromes.
The sponsor’s funded research reflects a focus on oncology within hematologic cancer treatment, including use in combination with other anti-cancer agents for progressive disease.
Oxcia AB runs clinical trials in conditions such as Haematological malignancy, among others.
Clinical trials run by this sponsor – those enrolling participants first.
DenmarkIncrease visibility for your trials and help patients find your site through our platform.
Tell us about your condition – we search every trial in Europe and connect you with the right site.
